Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 659

1.

Reproducibility of histologic prognostic parameters for mantle cell lymphoma: cytology, Ki67, p53 and SOX11.

Croci GA, Hoster E, Beà S, Clot G, Enjuanes A, Scott DW, Cabeçadas J, Veloza L, Campo E, Clasen-Linde E, Goswami RS, Helgeland L, Pileri S, Rymkiewicz G, Reinke S, Dreyling M, Klapper W.

Virchows Arch. 2020 Jan 23. doi: 10.1007/s00428-020-02750-7. [Epub ahead of print]

PMID:
31975037
2.

Breast implant-associated anaplastic large cell lymphoma: A comprehensive review.

Marra A, Viale G, Pileri SA, Pravettoni G, Viale G, De Lorenzi F, Nolè F, Veronesi P, Curigliano G.

Cancer Treat Rev. 2020 Jan 13;84:101963. doi: 10.1016/j.ctrv.2020.101963. [Epub ahead of print] Review.

PMID:
31958739
3.

Prospective assessment of NGS-detectable mutations in CML patients with non-optimal response: the NEXT-in-CML study.

Soverini S, Bavaro L, De Benedittis C, Martelli M, Iurlo A, Orofino N, Sica S, Sora F, Lunghi F, Ciceri F, Galimberti S, Baratè C, Bonifacio M, Scaffidi L, Castagnetti F, Gugliotta G, Albano F, Russo Rossi AV, Stagno F, Di Raimondo F, D'Adda M, Di Bona E, Abruzzese E, Binotto G, Sancetta R, Salvucci M, Capodanno I, Girasoli M, Coluzzi S, Attolico I, Musolino C, Calistri E, Annunziata M, Bocchia M, Stella S, Serra A, Errichiello S, Saglio G, Pane F, Vigneri PG, Mignone F, Laginestra MA, Pileri SA, Percesepe A, Tenti E, Rosti G, Baccarani M, Cavo M, Martinelli G.

Blood. 2019 Dec 26. pii: blood.2019002969. doi: 10.1182/blood.2019002969. [Epub ahead of print]

PMID:
31877211
4.

Expansion of PD1-positive T Cells in Nodal Marginal Zone Lymphoma: A Potential Diagnostic Pitfall.

Egan C, Laurent C, Alejo JC, Pileri S, Campo E, Swerdlow SH, Piris M, Chan WC, Warnke R, Gascoyne RD, Xi L, Raffeld M, Pittaluga S, Jaffe ES.

Am J Surg Pathol. 2019 Nov 22. doi: 10.1097/PAS.0000000000001414. [Epub ahead of print]

PMID:
31764221
5.

Novel markers in pediatric-type follicular lymphoma.

Agostinelli C, Akarca AU, Ramsay A, Rizvi H, Rodriguez-Justo M, Pomplun S, Proctor I, Sabattini E, Linch D, Daw S, Pittaluga S, Pileri SA, Jaffe ES, Quintanilla-Martinez L, Marafioti T.

Virchows Arch. 2019 Dec;475(6):771-779. doi: 10.1007/s00428-019-02681-y. Epub 2019 Nov 4.

6.

Correction to: A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit.

Di Napoli A, Remotti D, Agostinelli C, Ambrosio MR, Ascani S, Carbone A, Facchetti F, Lazzi S, Leoncini L, Lucioni M, Novero D, Pileri S, Ponzoni M, Sabattini E, Tripodo C, Zamò A, Paulli M, Ruco L.

Virchows Arch. 2019 Dec;475(6):799. doi: 10.1007/s00428-019-02696-5.

7.

Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry.

Amador C, Greiner TC, Heavican TB, Smith LM, Galvis KT, Lone W, Bouska A, D'Amore F, Pedersen MB, Pileri S, Agostinelli C, Feldman AL, Rosenwald A, Ott G, Mottok A, Savage KJ, de Leval L, Gaulard P, Lim ST, Ong CK, Ondrejka SL, Song J, Campo E, Jaffe ES, Staudt LM, Rimsza LM, Vose J, Weisenburger DD, Chan WC, Iqbal J.

Blood. 2019 Dec 12;134(24):2159-2170. doi: 10.1182/blood.2019000779.

PMID:
31562134
8.

Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified.

Laginestra MA, Cascione L, Motta G, Fuligni F, Agostinelli C, Rossi M, Sapienza MR, Righi S, Broccoli A, Indio V, Melle F, Tabanelli V, Calleri A, Novero D, Facchetti F, Inghirami G, Sabattini E, Bertoni F, Pileri SA.

Mod Pathol. 2019 Sep 26. doi: 10.1038/s41379-019-0376-8. [Epub ahead of print]

PMID:
31558781
9.

Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue.

Ciavarella S, Vegliante MC, Fabbri M, De Summa S, Melle F, Motta G, De Iuliis V, Opinto G, Enjuanes A, Rega S, Gulino A, Agostinelli C, Scattone A, Tommasi S, Mangia A, Mele F, Simone G, Zito AF, Ingravallo G, Vitolo U, Chiappella A, Tarella C, Gianni AM, Rambaldi A, Zinzani PL, Casadei B, Derenzini E, Loseto G, Pileri A, Tabanelli V, Fiori S, Rivas-Delgado A, López-Guillermo A, Venesio T, Sapino A, Campo E, Tripodo C, Guarini A, Pileri SA.

Ann Oncol. 2019 Dec 1;30(12):2015. doi: 10.1093/annonc/mdz386. No abstract available.

10.

A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit : A position paper from the Italian Group of Haematopathology (G.I.E.).

Di Napoli A, Remotti D, Agostinelli C, Ambrosio MR, Ascani S, Carbone A, Facchetti F, Lazzi S, Leoncini L, Lucioni M, Novero D, Pileri S, Ponzoni M, Sabattini E, Tripodo C, Zamò A, Paulli M, Ruco L.

Virchows Arch. 2019 Oct;475(4):513-518. doi: 10.1007/s00428-019-02637-2. Epub 2019 Aug 6. Erratum in: Virchows Arch. 2019 Oct 29;:.

11.

Diffuse large B-cell lymphoma: the stuff of cell-of-origin and microenvironment.

Pileri SA, Vegliante MC, Ciavarella S.

Oncotarget. 2019 Jun 18;10(40):3991-3993. doi: 10.18632/oncotarget.27013. eCollection 2019 Jun 18. No abstract available.

12.

Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant-associated anaplastic large cell lymphomas.

Tabanelli V, Corsini C, Fiori S, Agostinelli C, Calleri A, Orecchioni S, Melle F, Motta G, Rotili A, Di Napoli A, Pileri SA.

Hum Pathol. 2019 Aug;90:60-69. doi: 10.1016/j.humpath.2019.05.007. Epub 2019 May 21.

PMID:
31125630
13.

Blastic Plasmacytoid Dendritic Cell Neoplasm: State of the Art and Prospects.

Sapienza MR, Pileri A, Derenzini E, Melle F, Motta G, Fiori S, Calleri A, Pimpinelli N, Tabanelli V, Pileri S.

Cancers (Basel). 2019 Apr 28;11(5). pii: E595. doi: 10.3390/cancers11050595. Review.

14.

Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified.

Laginestra MA, Cascione L, Motta G, Fuligni F, Agostinelli C, Rossi M, Sapienza MR, Righi S, Broccoli A, Indio V, Melle F, Tabanelli V, Calleri A, Novero D, Facchetti F, Inghirami G, Sabattini E, Bertoni F, Pileri SA.

Mod Pathol. 2019 Apr 25. doi: 10.1038/s41379-019-0279-8. [Epub ahead of print] Erratum in: Mod Pathol. 2019 Sep 26;:.

PMID:
31028364
15.

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.

Heavican TB, Bouska A, Yu J, Lone W, Amador C, Gong Q, Zhang W, Li Y, Dave BJ, Nairismägi ML, Greiner TC, Vose J, Weisenburger DD, Lachel C, Wang C, Fu K, Stevens JM, Lim ST, Ong CK, Gascoyne RD, Missiaglia E, Lemonnier F, Haioun C, Hartmann S, Pedersen MB, Laginestra MA, Wilcox RA, Teh BT, Yoshida N, Ohshima K, Seto M, Rosenwald A, Ott G, Campo E, Rimsza LM, Jaffe ES, Braziel RM, d'Amore F, Inghirami G, Bertoni F, de Leval L, Gaulard P, Staudt LM, McKeithan TW, Pileri S, Chan WC, Iqbal J.

Blood. 2019 Apr 11;133(15):1664-1676. doi: 10.1182/blood-2018-09-872549. Epub 2019 Feb 19.

PMID:
30782609
16.

Dissecting diffuse large B-cell lymphomas of the "not otherwise specified" type: the impact of molecular techniques.

Pileri SA, Derenzini E, Melle F, Motta G, Calleri A, Antoniotti P, Maltoni V, Spagnolo S, Fiori S, Tabanelli V, Fabbri M.

F1000Res. 2018 Dec 21;7. pii: F1000 Faculty Rev-1966. doi: 10.12688/f1000research.16755.1. eCollection 2018. Review.

17.

Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target.

Sapienza MR, Abate F, Melle F, Orecchioni S, Fuligni F, Etebari M, Tabanelli V, Laginestra MA, Pileri A, Motta G, Rossi M, Agostinelli C, Sabattini E, Pimpinelli N, Truni M, Falini B, Cerroni L, Talarico G, Piccioni R, Amente S, Indio V, Tarantino G, Brundu F, Paulli M, Berti E, Facchetti F, Dellino GI, Bertolini F, Tripodo C, Rabadan R, Pileri SA.

Haematologica. 2019 Apr;104(4):729-737. doi: 10.3324/haematol.2018.202093. Epub 2018 Oct 31.

18.

Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue.

Ciavarella S, Vegliante MC, Fabbri M, De Summa S, Melle F, Motta G, De Iuliis V, Opinto G, Enjuanes A, Rega S, Gulino A, Agostinelli C, Scattone A, Tommasi S, Mangia A, Mele F, Simone G, Zito AF, Ingravallo G, Vitolo U, Chiappella A, Tarella C, Gianni AM, Rambaldi A, Zinzani PL, Casadei B, Derenzini E, Loseto G, Pileri A, Tabanelli V, Fiori S, Rivas-Delgado A, López-Guillermo A, Venesio T, Sapino A, Campo E, Tripodo C, Guarini A, Pileri SA.

Ann Oncol. 2018 Dec 1;29(12):2363-2370. doi: 10.1093/annonc/mdy450. Erratum in: Ann Oncol. 2019 Dec 1;30(12):2015.

19.

Granulysin, a novel marker for extranodal NK/T cell lymphoma, nasal type.

Lo Bello G, Akarca AU, Ambrosio MR, Agostinelli C, Molina-Kirsch H, Ramsay A, Rodriguez-Justo M, Pugh M, Zhao S, DeLisser M, Sabattini E, Dojcinov S, Pileri SA, Natkunam Y, Leoncini L, Marafioti T.

Virchows Arch. 2018 Dec;473(6):749-757. doi: 10.1007/s00428-018-2434-x. Epub 2018 Aug 27.

20.

CD30 expression in neoplastic T cells of follicular T cell lymphoma is a helpful diagnostic tool in the differential diagnosis of Hodgkin lymphoma.

Hartmann S, Goncharova O, Portyanko A, Sabattini E, Meinel J, Küppers R, Agostinelli C, Pileri SA, Hansmann ML.

Mod Pathol. 2019 Jan;32(1):37-47. doi: 10.1038/s41379-018-0108-5. Epub 2018 Aug 23.

21.

Genomic alterations of ribosomal protein genes in diffuse large B cell lymphoma.

Derenzini E, Agostinelli C, Rossi A, Rossi M, Scellato F, Melle F, Motta G, Fabbri M, Diop F, Kodipad AA, Chiappella A, Vitolo U, Gaidano G, Tarella C, Pileri S.

Br J Haematol. 2019 Apr;185(2):330-334. doi: 10.1111/bjh.15442. Epub 2018 Jun 17. No abstract available.

22.

slan+ Monocytes and Macrophages Mediate CD20-Dependent B-cell Lymphoma Elimination via ADCC and ADCP.

Vermi W, Micheletti A, Finotti G, Tecchio C, Calzetti F, Costa S, Bugatti M, Calza S, Agostinelli C, Pileri S, Balzarini P, Tucci A, Rossi G, Furlani L, Todeschini G, Zamò A, Facchetti F, Lorenzi L, Lonardi S, Cassatella MA.

Cancer Res. 2018 Jul 1;78(13):3544-3559. doi: 10.1158/0008-5472.CAN-17-2344. Epub 2018 May 10.

23.

Peripheral T cell lymphoma, not otherwise specified (PTCL-NOS). A new prognostic model developed by the International T cell Project Network.

Federico M, Bellei M, Marcheselli L, Schwartz M, Manni M, Tarantino V, Pileri S, Ko YH, Cabrera ME, Horwitz S, Kim WS, Shustov A, Foss FM, Nagler A, Carson K, Pinter-Brown LC, Montoto S, Spina M, Feldman TA, Lechowicz MJ, Smith SM, Lansigan F, Gabus R, Vose JM, Advani RH; T cell Project Network.

Br J Haematol. 2018 Jun;181(6):760-769. doi: 10.1111/bjh.15258. Epub 2018 Apr 19.

24.

Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi.

Zaja F, Salvi F, Rossi M, Sabattini E, Evangelista A, Ciccone G, Angelucci E, Gaidano G, Zanni M, Ladetto M, Chiappella A, Vitolo U, Zinzani PL, Califano C, Tucci A, Patti C, Pileri SA, Lenti V, Piccaluga PP, Cavallo F, Volpetti S, Perali G, Assouline S, Mann KK, Morin R, Alcaide M, Bushell K, Fanin R, Levis A.

Leuk Lymphoma. 2018 Dec;59(12):2904-2910. doi: 10.1080/10428194.2018.1452208. Epub 2018 Apr 4.

PMID:
29616865
25.

Long-term results of the AIEOP MH'96 childhood Hodgkin's lymphoma trial and focus on significance of response to chemotherapy and its implication in low risk patients to avoid radiotherapy.

Burnelli R, Rinieri S, Rondelli R, Todesco A, Bianchi M, Garaventa A, Zecca M, Indolfi P, Conter V, Santoro N, Aricò M, Cesaro S, D'amico S, Farruggia P, De Santis R, Locatelli F, Pileri SA, Scarzello G, Mascarin M, Vecchi V; AIEOP (Italian Association of Pediatric Hematology and Oncology) and Pediatric Hodgkin’s Lymphoma working Group.

Leuk Lymphoma. 2018 Nov;59(11):2612-2621. doi: 10.1080/10428194.2018.1435872. Epub 2018 Feb 16.

PMID:
29448858
26.

Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1.

Palmerini E, Agostinelli C, Picci P, Pileri S, Marafioti T, Lollini PL, Scotlandi K, Longhi A, Benassi MS, Ferrari S.

Oncotarget. 2017 Dec 4;8(67):111836-111846. doi: 10.18632/oncotarget.22912. eCollection 2017 Dec 19.

27.

Prospective subgroup analyses of the randomized MCL-002 (SPRINT) study: lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma.

Arcaini L, Lamy T, Walewski J, Belada D, Mayer J, Radford J, Jurczak W, Morschhauser F, Alexeeva J, Rule S, Cabeçadas J, Campo E, Pileri SA, Biyukov T, Patturajan M, Casadebaig Bravo ML, Trnĕný M; SPRINT Trial Investigators.

Br J Haematol. 2018 Jan;180(2):224-235. doi: 10.1111/bjh.15025. Epub 2017 Nov 28.

28.

Understanding lymphoma molecular complexity.

Pileri SA.

Blood. 2017 Oct 19;130(16):1780-1781. doi: 10.1182/blood-2017-08-802223. No abstract available.

PMID:
29051151
29.

Understanding CD30 biology and therapeutic targeting: a historical perspective providing insight into future directions.

van der Weyden CA, Pileri SA, Feldman AL, Whisstock J, Prince HM.

Blood Cancer J. 2017 Sep 8;7(9):e603. doi: 10.1038/bcj.2017.85. Review.

30.

Primary bone lymphoma of the talus: a challenging diagnosis.

Annibali O, Fabbriciani G, Tafuri M, Massarotti M, Sedati P, Tomarchio V, Sabattini E, Pileri S, Selmi C, Avvisati G.

Tumori. 2017 Nov 15;103(Suppl. 1):e62-e65. doi: 10.5301/tj.5000648.

PMID:
28862737
31.

The clinicopathologic spectrum of mature aggressive B cell lymphomas.

Rimsza L, Pittaluga S, Dirnhofer S, Copie-Bergman C, de Leval L, Facchetti F, Pileri S, Rosenwald A, Wotherspoon A, Fend F.

Virchows Arch. 2017 Oct;471(4):453-466. doi: 10.1007/s00428-017-2199-7. Epub 2017 Aug 26. Review.

PMID:
28844114
32.

Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases.

Facchetti F, Pileri SA, Lorenzi L, Tabanelli V, Rimsza L, Pittaluga S, Dirnhofer S, Copie-Bergman C, de Leval L, Rosenwald A, Wotherspoon A, Fend F.

Virchows Arch. 2017 Oct;471(4):467-489. doi: 10.1007/s00428-017-2176-1. Epub 2017 Jul 10.

PMID:
28695297
33.

Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study.

Chiappella A, Martelli M, Angelucci E, Brusamolino E, Evangelista A, Carella AM, Stelitano C, Rossi G, Balzarotti M, Merli F, Gaidano G, Pavone V, Rigacci L, Zaja F, D'Arco A, Cascavilla N, Russo E, Castellino A, Gotti M, Congiu AG, Cabras MG, Tucci A, Agostinelli C, Ciccone G, Pileri SA, Vitolo U.

Lancet Oncol. 2017 Aug;18(8):1076-1088. doi: 10.1016/S1470-2045(17)30444-8. Epub 2017 Jun 28.

PMID:
28668386
34.

B-cell lymphomas with discordance between pathological features and clinical behavior.

de Leval L, Copie-Bergman C, Rosenwald A, Rimsza L, Pittaluga S, Bisig B, Dirnhofer S, Facchetti F, Pileri S, Fend F, Wotherspoon A.

Virchows Arch. 2017 Oct;471(4):439-451. doi: 10.1007/s00428-017-2152-9. Epub 2017 Jun 1.

PMID:
28573510
35.

SOX-11 detection in decalcified bone marrow tissue in mantle cell lymphoma patients, methodological issue on reproducibility and validity-reply.

Agostinelli C, Sabattini E, Pileri SA, Fabbri M.

Hum Pathol. 2017 Aug;66:238-239. doi: 10.1016/j.humpath.2017.02.029. Epub 2017 Apr 28. No abstract available.

PMID:
28461033
36.

Langerhans, plasmacytoid dendritic and myeloid-derived suppressor cell levels in mycosis fungoides vary according to the stage of the disease.

Pileri A, Agostinelli C, Sessa M, Quaglino P, Santucci M, Tomasini C, Grandi V, Fava P, Astrua C, Righi S, Patrizi A, Pileri SA, Pimpinelli N.

Virchows Arch. 2017 May;470(5):575-582. doi: 10.1007/s00428-017-2107-1. Epub 2017 Mar 20.

PMID:
28321511
37.

Pathology of nodal marginal zone lymphomas.

Pileri S, Ponzoni M.

Best Pract Res Clin Haematol. 2017 Mar - Jun;30(1-2):50-55. doi: 10.1016/j.beha.2016.11.001. Epub 2016 Dec 5. Review.

PMID:
28288717
38.

The pathobiology and treatment of Hodgkin lymphoma. Where do we go from Gianni Bonadonna's lesson?

Viviani S, Tabanelli V, Pileri SA.

Tumori. 2017 Mar 24;103(2):101-113. doi: 10.5301/tj.5000608. Epub 2017 Feb 22. Review.

PMID:
28233887
39.

The emerging role of GSK-3β in the pathobiology of classical Hodgkin lymphoma.

Agostinelli C, Carloni S, Limarzi F, Righi S, Laginestra MA, Musuraca G, Fiorentino M, Napolitano R, Cuneo A, Vergara D, Zinzani PL, Sabattini E, Pileri SA, De Matteis S.

Histopathology. 2017 Jul;71(1):72-80. doi: 10.1111/his.13189. Epub 2017 Apr 11.

PMID:
28208230
40.

Randomized Trial Comparing R-CHOP Versus High-Dose Sequential Chemotherapy in High-Risk Patients With Diffuse Large B-Cell Lymphomas.

Cortelazzo S, Tarella C, Gianni AM, Ladetto M, Barbui AM, Rossi A, Gritti G, Corradini P, Di Nicola M, Patti C, Mulé A, Zanni M, Zoli V, Billio A, Piccin A, Negri G, Castellino C, Di Raimondo F, Ferreri AJ, Benedetti F, La Nasa G, Gini G, Trentin L, Frezzato M, Flenghi L, Falorio S, Chilosi M, Bruna R, Tabanelli V, Pileri S, Masciulli A, Delaini F, Boschini C, Rambaldi A.

J Clin Oncol. 2016 Nov 20;34(33):4015-4022. doi: 10.1200/JCO.2016.67.2980. Epub 2016 Oct 31.

41.

Prevention of large-scale implementation of unnecessary and expensive predictive tests in Hodgkin's lymphoma - Authors' reply.

Agostinelli C, Gallamin A, Fuligni F, Stracqualursi L, Agati P, Zinzani PL, Pileri SA.

Lancet Haematol. 2017 Feb;4(2):e64-e66. doi: 10.1016/S2352-3026(17)30002-9. No abstract available.

PMID:
28159191
42.

Identification of novel follicular dendritic cell sarcoma markers, FDCSP and SRGN, by whole transcriptome sequencing.

Lorenzi L, Döring C, Rausch T, Benes V, Lonardi S, Bugatti M, Campo E, Cabeçadas J, Simonitsch-Klupp I, Borges A, Mehta J, Agostinelli C, Pileri SA, Facchetti F, Hansmann ML, Hartmann S.

Oncotarget. 2017 Mar 7;8(10):16463-16472. doi: 10.18632/oncotarget.14864.

43.

Distinctive Histogenesis and Immunological Microenvironment Based on Transcriptional Profiles of Follicular Dendritic Cell Sarcomas.

Laginestra MA, Tripodo C, Agostinelli C, Motta G, Hartmann S, Döring C, Rossi M, Melle F, Sapienza MR, Tabanelli V, Pileri A, Fuligni F, Gazzola A, Mannu C, Sagramoso CA, Lonardi S, Lorenzi L, Bacci F, Sabattini E, Borges A, Simonitsch-Klupp I, Cabecadas J, Campo E, Rosai J, Hansmann ML, Facchetti F, Pileri SA.

Mol Cancer Res. 2017 May;15(5):541-552. doi: 10.1158/1541-7786.MCR-16-0301. Epub 2017 Jan 27.

44.

Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: a phase II clinical trial of the Fondazione Italiana Linfomi.

Zaja F, Ferrero S, Stelitano C, Ferrari A, Salvi F, Arcari A, Musuraca G, Botto B, Spina M, Cellini C, Patti C, Liberati AM, Minotto C, Pileri SA, Ceccarelli M, Volpetti S, Ferranti A, Drandi D, Montechiarello E, Ladetto M, Carmichael J, Fanin R.

Haematologica. 2017 May;102(5):e203-e206. doi: 10.3324/haematol.2016.154211. Epub 2017 Jan 12. No abstract available.

45.

Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas.

Abate F, da Silva-Almeida AC, Zairis S, Robles-Valero J, Couronne L, Khiabanian H, Quinn SA, Kim MY, Laginestra MA, Kim C, Fiore D, Bhagat G, Piris MA, Campo E, Lossos IS, Bernard OA, Inghirami G, Pileri S, Bustelo XR, Rabadan R, Ferrando AA, Palomero T.

Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):764-769. doi: 10.1073/pnas.1608839114. Epub 2017 Jan 6.

46.

Pelvic myeloid sarcoma: a multidisciplinary approach.

Seracchioli R, Geraci E, Paradisi R, Montanari G, Zannoni L, Tabanelli V, Pileri SA, Carloni S, Sartor C, Martinelli G.

Eur J Gynaecol Oncol. 2017;38(3):476-478.

PMID:
29693897
47.

Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi.

Visco C, Chiappella A, Nassi L, Patti C, Ferrero S, Barbero D, Evangelista A, Spina M, Molinari A, Rigacci L, Tani M, Rocco AD, Pinotti G, Fabbri A, Zambello R, Finotto S, Gotti M, Carella AM, Salvi F, Pileri SA, Ladetto M, Ciccone G, Gaidano G, Ruggeri M, Martelli M, Vitolo U.

Lancet Haematol. 2017 Jan;4(1):e15-e23. doi: 10.1016/S2352-3026(16)30185-5. Epub 2016 Dec 5.

PMID:
27927586
48.

Cytotoxic Epstein-Barr virus-positive large B cell lymphoma: a regulatory B cell-derived neoplasia?

Tabanelli V, Santiago-Pacheco V, Corbellino M, Calleri A, Agostinelli C, Parravicini C, Pileri SA.

Histopathology. 2017 Mar;70(4):650-656. doi: 10.1111/his.13109. Epub 2016 Dec 20.

PMID:
27782313
49.

Reproducibility of SOX-11 detection in decalcified bone marrow tissue in mantle cell lymphoma patients.

Righi S, Pileri S, Agostinelli C, Bacci F, Spagnolo S, Sabattini E.

Hum Pathol. 2017 Jan;59:94-101. doi: 10.1016/j.humpath.2016.09.018. Epub 2016 Oct 5.

PMID:
27720733
50.

CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies?

Zaja F, Tabanelli V, Agostinelli C, Calleri A, Chiappella A, Varettoni M, Luigi Zinzani P, Volpetti S, Sabattini E, Fanin R, Pileri SA.

Am J Hematol. 2017 Jan;92(1):E1-E2. doi: 10.1002/ajh.24571. Epub 2016 Nov 10. No abstract available.

Supplemental Content

Loading ...
Support Center